SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY ARTICLE L impact

Spyre Therapeutics announces inducement awards grants

Spyre Therapeutics said it has announced grants of inducement awards, per a Globe Newswire release dated Sept. 04, 2026.

SYRE

WALTHAM, Mass., Sept.

04, 2026 (GLOBE NEWSWIRE) -- Spyre Therapeutics, Inc.

NASDAQ:SYRE (the “Company” or “Spyre”), a clinical-stage biotechnology company committed to developing next-generation therapies that elevate the standard in immunology by delivering more complete disease control, greater d…